Aropha, a leading laboratory focused on advancing biodegradable material discovery and testing through lab automation and AI predictive modeling, today announced that it has raised $1 million in a Series Seed funding round. The round was led by Comeback Capital, with participation from Lightbank and Right Side Capital Management (RSCM).
Aropha works directly with companies to provide rapid biodegradation testing and implement AI screening into their product development processes. The funding will be used to expand Aropha’s current laboratory operations, increase industry awareness, and fund the development of its biodegradation prediction model, ArophaAI.
With over 145,000 tonnes of microplastics used in the EU each year and new legislation requiring 100% of single-use packaging to be recyclable or compostable by 2032 in California, the demand for cost-effective and efficient biodegradation testing is rapidly increasing. Aropha is well-positioned to significantly impact the testing industry, as even one of the most common, short biodegradation studies may cost over $10,000 according to the EPA with some complex, lab-based simulation tests reaching over $300,000.
To date, Aropha has helped more than 80 customers with their biodegradation testing through both in-lab and in-silico testing. Year-over-year booked revenue at the end of Q4 saw 190% growth. The company also recently published a free version of its predictive model, ArophaAI-2.
Aropha plans to continue expanding its current testing facility, invest heavily in its predictive model development, and strengthen relationships with long-term partners and appropriate accreditation bodies.
Like this:
Like Loading...
Related
This entry was posted on April 24, 2024 at 8:38 am and is filed under Commentary with tags Aropha. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Aropha Raises $1M in Seed Funding to Revolutionize Biodegradable Material Testing with AI and Lab Automation
Aropha, a leading laboratory focused on advancing biodegradable material discovery and testing through lab automation and AI predictive modeling, today announced that it has raised $1 million in a Series Seed funding round. The round was led by Comeback Capital, with participation from Lightbank and Right Side Capital Management (RSCM).
Aropha works directly with companies to provide rapid biodegradation testing and implement AI screening into their product development processes. The funding will be used to expand Aropha’s current laboratory operations, increase industry awareness, and fund the development of its biodegradation prediction model, ArophaAI.
With over 145,000 tonnes of microplastics used in the EU each year and new legislation requiring 100% of single-use packaging to be recyclable or compostable by 2032 in California, the demand for cost-effective and efficient biodegradation testing is rapidly increasing. Aropha is well-positioned to significantly impact the testing industry, as even one of the most common, short biodegradation studies may cost over $10,000 according to the EPA with some complex, lab-based simulation tests reaching over $300,000.
To date, Aropha has helped more than 80 customers with their biodegradation testing through both in-lab and in-silico testing. Year-over-year booked revenue at the end of Q4 saw 190% growth. The company also recently published a free version of its predictive model, ArophaAI-2.
Aropha plans to continue expanding its current testing facility, invest heavily in its predictive model development, and strengthen relationships with long-term partners and appropriate accreditation bodies.
Share this:
Like this:
Related
This entry was posted on April 24, 2024 at 8:38 am and is filed under Commentary with tags Aropha. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.